MA
TMDX icon

MCF Advisors’s Transmedics TMDX Stock Holding History

MCF Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66K Sell
25
-112
-82% -$9.48K ﹤0.01% 1291
2026
Q1 		$13.6K Hold
137
– – ﹤0.01% 900
2025
Q4 		$16.7K Buy
137
+75
+121% +$9.41K ﹤0.01% 728
2025
Q3 		$6.96K Sell
62
-78
-56% -$9.13K ﹤0.01% 753
2025
Q2 		$18.8K Buy
+140
New +$15.4K ﹤0.01% 561
2024
Q4 		– Sell
-291
Closed -$45.7K – 1046
2024
Q3 		$45.7K Sell
291
-76
-21% -$11.7K ﹤0.01% 411
2024
Q2 		$55.3K Sell
367
-190
-34% -$22.8K ﹤0.01% 366
2024
Q1 		$41.2K Hold
557
– – ﹤0.01% 411
2023
Q4 		$44K Sell
557
-29
-5% -$1.75K ﹤0.01% 388
2023
Q3 		$32.1K Buy
586
+37
+7% +$2.66K ﹤0.01% 416
2023
Q2 		$46.1K Sell
549
-62
-10% -$4.75K ﹤0.01% 371
2023
Q1 		$46.3K Sell
611
-184
-23% -$12.7K ﹤0.01% 365
2022
Q4 		$49.1K Sell
795
-247
-24% -$13.1K 0.01% 345
2022
Q3 		$43K Buy
+1,042
New +$45.3K ﹤0.01% 354

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

MCF Advisors's TMDX Position: Q2 2026 in Review

MCF Advisors reduced its Transmedics (TMDX) stake by 82% in Q2 2026, selling an estimated $9.48K and leaving 25 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

MCF Advisors first reported a position in TMDX in Q3 2022 and has held it in 14 quarters since. The position peaked at $55.3K in Q2 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • MCF Advisors held 25 shares of Transmedics worth $1.66K as of Q2 2026.
  • MCF Advisors sold 112 Transmedics shares in Q2 2026, an estimated $9.48K.
  • Transmedics made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1291 holding.
  • MCF Advisors first reported a position in Transmedics in Q3 2022 and has held it in 14 quarters since.
  • MCF Advisors's Transmedics position peaked at $55.3K in Q2 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.